CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-11
DOI
10.1038/s41388-020-01412-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2
- (2019) Laura Duciel et al. Scientific Reports
- Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions
- (2019) Aubin Moutal et al. MOLECULAR NEUROBIOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines
- (2018) Wei Yan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia
- (2018) Yue Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage
- (2018) Hiroki Abe et al. SCIENCE
- Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation
- (2018) Yiyan Zheng et al. Nature Communications
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer
- (2018) Ryoichi Matsunuma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation
- (2017) Aubin Moutal et al. MOLECULAR NEUROBIOLOGY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Clinical Diagnosis and Management of Breast Cancer
- (2016) E. S. McDonald et al. JOURNAL OF NUCLEAR MEDICINE
- Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis
- (2015) Nicola J. Grant et al. BMC CANCER
- CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases
- (2015) T T Quach et al. MOLECULAR PSYCHIATRY
- Movers and shakers: cell cytoskeleton in cancer metastasis
- (2014) C M Fife et al. BRITISH JOURNAL OF PHARMACOLOGY
- Breast cancer stem cells: Multiple capacities in tumor metastasis
- (2014) Shao-Qing Geng et al. CANCER LETTERS
- RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch
- (2014) L A Walsh et al. ONCOGENE
- Emerging targeted agents in metastatic breast cancer
- (2013) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Collapsin response mediator protein 2 is involved in regulating breast cancer progression
- (2013) Kazuhiro Shimada et al. Breast Cancer
- An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
- (2013) R Y-J Huang et al. Cell Death & Disease
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
- (2012) Erik Oliemuller et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
- (2012) Y. Wu et al. MOLECULAR CANCER RESEARCH
- Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization
- (2012) S.M. Wilson et al. NEUROSCIENCE
- α-Mangostin Suppresses Phorbol 12-myristate 13-acetate-Induced MMP-2/MMP-9 Expressions via αvβ3 Integrin/FAK/ERK and NF-κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells
- (2010) Yuan-Wei Shih et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Toll-like Receptor and RIG-1-like Receptor Signaling
- (2009) Taro Kawai et al. Annals of the New York Academy of Sciences
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search